Antithrombin Concentrate Use in Children Receiving Unfractionated Heparin for Acute Thrombosis.

Objective: To characterize features of antithrombin concentrate (ATC) use in children receiving unfractionated heparin (UFH) therapy for acute thrombosis.

Study Design: All pediatric patients at Texas Children's Hospital who received ATC in the context of UFH therapy for acute thrombosis during February 2011 to May 2013 were analyzed.

Results: Fifty-one children received ATC during UFH therapy for acute thrombosis.